TheBOX product lineup showing single chamber, dual chamber, and quad chamber vapor infusion systems

Investment

The Price

The cost of in-process control is visible. The cost of its absence compounds invisibly—until it doesn't.

Process control infrastructure investment designed for operators who understand long-term value over short-term cost.

Three Dimensions of True Cost

The cost of uncontrolled microbial risk expresses itself across three dimensions—each operating on a different timeline, each compounding in its own way.

Dimension One — Immediate

Yield Loss

Compliance failures. Downgraded flower. Conversion to oil. Destroyed batches. This is the visible cost of unmanaged biology — and the baseline consequence of operating without proactive compliance infrastructure.

Dimension Two — Delayed

Recall Exposure

Product passes testing, ships into market, contamination resurfaces weeks or months later. Product must be pulled, destroyed, or litigated.

Dimension Three — Compounding

Brand & Reputation Risk

Retail hesitation. Distributor distrust. Regulatory scrutiny. Insurance premium increases. Loss of pricing power. One recall can erase years of brand equity.

The Biological Reality

On the order of ~20% of harvested flower value is lost before reaching full retail price. This is not a performance claim—it is the biological consequence of contamination that compounds over time. Fungi and microbes do not remain static. Residual contamination can shift from paralysis to regrowth during storage, distribution, and shelf life. Pharmaceutical manufacturing addresses this at the process level, not post-failure — building compliance into the production step itself rather than treating non-compliance as an acceptable cost of doing business. Even closing part of that gap justifies the investment in process control.

Investment Framework

Process control infrastructure pays for itself through loss prevention, not just efficiency gains. The value is measured in what doesn't happen.

01

Compliance assurance
non-compliance costs avoided, not just efficiency improved

02

Risk transfer
liability shifted from absorption to prevention

03

Brand durability
reputation protected through operational discipline

Indicative Investment Ranges

Pricing shown as indicative ranges (±). Final configuration depends on throughput, facility layout, and contamination profile.

Used purification systems

Recovered Capacity Deployment

~$75,000

  • Designed for operators reclaiming margin from existing production
  • No facility overhaul required
  • Fastest path to immediate operational impact

Ideal for craft and emerging operations

New purification systems

Primary Process Control Deployment

Starting ~ $95,000

  • Establishes in-process microbial control as a permanent layer
  • Built for repeatability, validation, and scale
  • Ideal for consistent commercial operations

Built for growing commercial operations

Custom-engineered systems

Custom Integrated Deployment

~$250,000+

  • Multi-chamber or facility-integrated configurations
  • Designed for high-throughput or enterprise environments
  • Optimized for long-term margin protection and risk reduction

Designed for enterprise and MSO deployment

All pricing is indicative (±). Final investment varies by configuration.

Why This Isn't a Cost — It's a Margin Control Layer

Uncontrolled biology quietly taxes margin every month.

In-process purification removes that tax before it compounds.

Recovered margin is realized continuously — not annually.

Operators typically see ~20% monthly improvement in usable yield and sell-through efficiency once microbial risk is controlled in process — the pharmaceutical-grade standard for proactive compliance, not post-event remediation.

By placing remaining fungal populations into a suspended, non-reproductive state, in-process purification does more than pass today's test. It reduces delayed microbial resurgence, extends shelf life, and protects revenue weeks or months later.

What's Included

Equipment

Complete System

TheBOX® unit with vacuum chamber, control system, and all hardware required for validated operation.

Services

Installation & Training

On-site installation, operator training, and validation protocol support included with every system.

Ongoing

Support & Consumables

Technical support, maintenance scheduling, and consumable supply programs tailored to your operation.

Interactive Calculator

Estimate Your Margin Recovery

Explore how TheBOX® in-process purification may help protect your operation's margins from batch failures, shelf-life decay, and downstream risk exposure.

This calculator provides estimates for planning purposes. TheBOX® is a production tool, not a financial guarantee. Results depend on operation-specific factors.

Your Operation

lbs
$/lb
%
%
$1000/lb flower → $400/lb extraction = $600 loss per failed pound
% / mo
%

Avoided Downgrade Value (Optional)

Enter the value retained per pound by avoiding forced extraction or discount pricing on protected batches.

$/lb

Loss Prevention & Margin Protection

Margin Protected

$0/mo

Annual Profit Stabilized

$0/yr

Based on current throughput and historical failure rate

Current Exposure

$0/mo

Protected per Pound

$0

Shelf-Life Preserved

$0/mo

Downgrade Prevention

$0/mo

Downstream Risk Visualization

Visual illustration of exposure and protection — not predictive outcomes

Risk Exposure Comparison

Without Protection$0
With TheBOX®$0
0% exposure reduction

Shelf-Life Value Trajectory

100%50%0%
M0M1M2M3M4M5M6
Standard decay
With TheBOX®

Illustrative trajectory — actual results depend on storage conditions

Estimates based on user-provided inputs and typical industry data. Actual results may vary. Consult with TheBOX® team for operation-specific analysis.

What is the cost of operating without pharmaceutical-grade compliance infrastructure — and how long has that cost been compounding?

Retrofitting process control infrastructure under regulatory deadline costs significantly more than building it in from the start. Operators who wait face simultaneous cost pressure from new compliance requirements and lost revenue during transition.

Source: USP Chapter 1568 draft standards, 2025; FDA Guidance for Industry, “Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research”

Evaluate Your Margin Recovery Potential

We don't start with equipment. We start by identifying where uncontrolled biology is leaking margin from your operation.

Talk to a Specialist

Process Control for Regulated Cannabis Operations